Journal of Leukocyte Biology Myeloid cells, immune suppression, tumor immunology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


A more recent version of this article appeared on May 1, 2006

Published online before print March 7, 2006
This Article
Right arrow Full Text (Reprint (PDF))
Right arrow All Versions of this Article:
jlb.0805452v1
79/5/1022    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rittner, H. L.
Right arrow Articles by Brack, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rittner, H. L.
Right arrow Articles by Brack, A.
Related Collections
Right arrowRelated Articles
© by The Society for Leukocyte Biology
Journal of Leukocyte Biology, doi:10.1189/jlb.0805452


Received for publication August 13, 2005.
Revised December 27, 2005.
Accepted for publication January 5, 2006.


Article

Selective local PMN recruitment by CXCL1 or CXCL2/3 injection does not cause inflammatory pain

Heike L. Rittner , Shaaban A. Mousa , Dominika Labuz , Karin Beschmann , Michael Schäfer , Christoph Stein , and Alexander Brack @

Klinik für Anaesthesiologie und operative Intensivmedizin, Charité-Universitätsmedizin Berlin, Campus Benjamin Franklin, Germany

@ To whom correspondence should be addressed. E-mail: alexander.brack{at}charite.de.


   Abstract

Polymorphonuclear cells (PMN) are recruited in early inflammation and are believed to contribute to inflammatory pain. However, studies demonstrating a hyperalgesic role of PMN did not examine selective PMN recruitment or did not document effective PMN recruitment. We hypothesized that hyperalgesia does not develop after chemokine-induced PMN selective recruitment and is independent of PMN infiltration in complete Freund’s adjuvant (CFA)-induced, local inflammation. PMN were recruited by intraplantar injection of CXC chemokine ligand 1 (CXCL1; keratinocyte-derived chemokine), CXCL2/3 (macrophage inflammatory protein-2), or CFA, with or without preceding systemic PMN depletion. Chemokine inoculation resulted in dose (0-30 µg)- and time (0-12 h)-dependent, selective recruitment of PMN as quantified by flow cytometry. CXCL2/3, but not CXCL1, was less effective at high doses, probably as a result of significant down-regulation of CXC chemokine receptor 2 expression on blood PMN. Neither chemokine caused mechanical or thermal hyperalgesia as determined by the Randall-Selitto and Hargreaves test, respectively, despite comparable expression of activation markers (i.e., CD11b, CD18, and L-selectin) on infiltrating PMN. In contrast, CFA injection induced hyperalgesia, independent of PMN recruitment. c-Fos mRNA and immunoreactivity in the spinal cord were increased significantly after inoculation of CFA, independent of PMN migration but not of CXCL2/3. Measurement of potential hyperalgesic mediators showed that hyperalgesia correlated with local prostaglandin E2 (PGE2) but not with interleukin-1{beta} production. In summary, hyperalgesia, local PGE2 production, and spinal c-Fos expression occur after CFA-induced inflammation but not after CXCL1- or CXCL2/3-induced, selective PMN recruitment. Thus, PMN seem to be less important in inflammatory hyperalgesia than previously thought.

Key Words: chemokine • CXCR2 • neutrophil • hyperalgesia • complete Freund’s adjuvant


Related Articles

Neutrophils: are they hyperalgesic or anti-hyperalgesic?
T. M. Cunha and W. A. Verri, Jr
J. Leukoc. Biol. 2006 80: 727-728. [Full Text] [PDF]

Comment on "Neutrophils: are they hyperalgesic or anti-hyperalgesic?"
Heike L. Rittner, Halina Machelska, Michael Schäfer, Christoph Stein, and Alexander Brack
J. Leukoc. Biol. 2006 80: 729-730. [Full Text] [PDF]



This article has been cited by other articles:


Home page
J. Leukoc. Biol.Home page
T. M. Cunha, W. A. Verri Jr., I. R. Schivo, M. H. Napimoga, C. A. Parada, S. Poole, M. M. Teixeira, S. H. Ferreira, and F. Q. Cunha
Crucial role of neutrophils in the development of mechanical inflammatory hypernociception
J. Leukoc. Biol., April 1, 2008; 83(4): 824 - 832.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
S. A Mousa, R. H Straub, M. Schafer, and C. Stein
{beta}-Endorphin, Met-enkephalin and corresponding opioid receptors within synovium of patients with joint trauma, osteoarthritis and rheumatoid arthritis
Ann Rheum Dis, July 1, 2007; 66(7): 871 - 879.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
H. L. Rittner, D. Labuz, M. Schaefer, S. A. Mousa, S. Schulz, M. Schafer, C. Stein, and A. Brack
Pain control by CXCR2 ligands through Ca2+-regulated release of opioid peptides from polymorphonuclear cells
FASEB J, December 1, 2006; 20(14): 2627 - 2629.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
H. L. Rittner, H. Machelska, M. Schafer, C. Stein, and A. Brack
Comment on "Neutrophils: are they hyperalgesic or anti-hyperalgesic?"
J. Leukoc. Biol., October 1, 2006; 80(4): 729 - 730.
[Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
T. M. Cunha and W. A. Verri Jr
Neutrophils: are they hyperalgesic or anti-hyperalgesic?
J. Leukoc. Biol., October 1, 2006; 80(4): 727 - 728.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2006 by the Society for Leukocyte Biology.